# iNtRON Biotechnology

> iNtRON Biotechnology is a VC fund backing Health Care and Biotechnology. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Seongnam, South Korea
- Total investments: 2
- Last investment: Jan 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/intron-biotechnology/
- X (Twitter): https://twitter.com/IntronB
- Website: https://intodeworld.com

iNtRON Biotechnology is a VC fund in Seongnam focused on Health Care and Biotechnology. iNtRON Biotechnology develops and manufactures molecular diagnostic assays based on real-time PCR and multiplex PCR kits.

## Contacts

5 contacts available for iNtRON Biotechnology. Shizune tracks 2 team members at iNtRON Biotechnology. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/intron-biotechnology-010c?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kyung-won Yoon | CEO/ Vice President | 1 | — |
| Sung-Soo Jang | CEO and President | 0 | — |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LISCure Biosciences | LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $13.6M | Venture - Series Unknown | Jan 10, 2025 |  |
| LISCure Biosciences | LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $9.3M | Series B | Dec 31, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Muirwoods Ventures](https://shizune.co/investors/profile/muirwoods-ventures) — VC Fund, 2 deals together
- [ROI Investment Partners](https://shizune.co/investors/profile/dadam-investment) — VC Fund, 1 deal together
- [Dt& Investment](https://shizune.co/investors/profile/dt-investment) — VC Fund, 1 deal together
- [Hana Financial Investment](https://shizune.co/investors/profile/hana-financial-investment) — VC Fund, 1 deal together
- [Hana Securities](https://shizune.co/investors/profile/hana-securities) — VC Fund, 1 deal together
- [IBK Securities](https://shizune.co/investors/profile/ibk-securities) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does iNtRON Biotechnology invest in?

iNtRON Biotechnology invests primarily in Health Care and Biotechnology startups, most often at Series B and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact iNtRON Biotechnology?

Public channels for iNtRON Biotechnology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at iNtRON Biotechnology?

The team at iNtRON Biotechnology includes Kyung-won Yoon (CEO/ Vice President) and Sung-Soo Jang (CEO and President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co